These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. Broome CV; Facklam RR; Fraser DW N Engl J Med; 1980 Sep; 303(10):549-52. PubMed ID: 6995835 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease. Fiore AE; Levine OS; Elliott JA; Facklam RR; Butler JC Emerg Infect Dis; 1999; 5(6):828-31. PubMed ID: 10603221 [TBL] [Abstract][Full Text] [Related]
5. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454 [TBL] [Abstract][Full Text] [Related]
7. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
8. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Hausdorff WP; Bryant J; Kloek C; Paradiso PR; Siber GR Clin Infect Dis; 2000 Jan; 30(1):122-40. PubMed ID: 10619741 [TBL] [Abstract][Full Text] [Related]
9. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases. Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ; Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland. Hjálmarsdóttir MÁ; Quirk SJ; Haraldsson G; Erlendsdóttir H; Haraldsson Á; Kristinsson KG PLoS One; 2017; 12(1):e0169210. PubMed ID: 28125588 [TBL] [Abstract][Full Text] [Related]
11. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy]. Motlová J Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381 [TBL] [Abstract][Full Text] [Related]
12. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. Shapiro ED; Berg AT; Austrian R; Schroeder D; Parcells V; Margolis A; Adair RK; Clemens JD N Engl J Med; 1991 Nov; 325(21):1453-60. PubMed ID: 1944423 [TBL] [Abstract][Full Text] [Related]
13. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage. Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501 [TBL] [Abstract][Full Text] [Related]
14. Inefficacy of pneumococcal vaccine in a high-risk population. Forrester HL; Jahnigen DW; LaForce FM Am J Med; 1987 Sep; 83(3):425-30. PubMed ID: 3661581 [TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program. Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038 [TBL] [Abstract][Full Text] [Related]
16. Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage. Principi N; Terranova L; Zampiero A; Montinaro V; Ierardi V; Peves Rios W; Pelucchi C; Esposito S Pediatr Infect Dis J; 2015 Apr; 34(4):426-32. PubMed ID: 25760567 [TBL] [Abstract][Full Text] [Related]
17. Pneumococcal disease in a medium-sized community in the United States. Mufson MA; Oley G; Hughey D JAMA; 1982 Sep; 248(12):1486-9. PubMed ID: 7109171 [TBL] [Abstract][Full Text] [Related]
18. Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine. Dixon JM; Lipinski AE Can Med Assoc J; 1981 Aug; 125(3):263-7. PubMed ID: 7272879 [TBL] [Abstract][Full Text] [Related]
19. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention? Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186 [TBL] [Abstract][Full Text] [Related]
20. Serotyping of 1,458 pneumococcal isolates with analysis of bacteremia in 84 patients. Fanciullo GJ; Baltch AL; Smith RP; Hollick G; Shayegani M South Med J; 1986 Nov; 79(11):1370-5. PubMed ID: 3775464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]